Results for adar poonawalla

Add to feed Create your own feed

Latest

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said he met Union Home Minister Amit Shah and apprised him about the ongoing COVID-19 vaccine rollout in the country.

'It was my honour to brief you today, Amit Shah Ji on the vaccine capabilities of our country and the ongoing rollout of vaccines in India,' tweeted Adar Poonawalla

It's a historic moment for all of us as COVAX receives its first doses of Oxford-AstraZeneca vaccine made by SII, 'COVISHEILD'. SII will continue to be at forefront of fighting the pandemic with affordable & immunogenic vaccines: Serum Institute of India CEO Adar Poonawalla

tweet picture

It's a historic moment for all of us as COVAX receives its first doses of Oxford-AstraZeneca vaccine made by SII, 'COVISHEILD'. SII will continue to be at forefront of fighting the pandemic with affordable & immunogenic vaccines: Serum Institute of India CEO Adar Poonawalla

Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of COVID-19 vaccine, Covishield, as the company has been directed to prioritise the needs of India.

Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs

'Be patient': Serum's Adar Poonawalla to foreign countries waiting for Covishield supplies.

Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, Adar Poonawalla, CEO of vaccine major Serum Institute of India, said

Adar Poonawalla, CEO of #SerumInstituteofIndia  (SII), today urged countries to be patient for supplies of #COVID19Vaccine  #COVISHIELD , as the company has been directed to prioritise the "huge needs" of #India 

Loading
Loading

Most relevant

#ETAwards | Entrepreneur of the year: Adar Poonawalla Chief Executive Officer, Serum Institute of India @adarpoonawalla 

#NDTVExclusive | “Adar Poonawalla is a friend and I admire him for what he is doing.. but between being for or against the vaccine, a middle path – do the risks outweigh the benefits? For someone like me, I believe they do,” says Rajiv Bajaj, MD, Bajaj Auto#ExecutiveDecision 

#WATCH | Pune: Serum Institute of India CEO Adar Poonawalla receives a shot of #COVISHIELD  vaccine manufactured by his company. (Video credit - Poonawalla's Twitter account)

Thank you everyone for your concern & prayers. So far the most important thing is that there've been no lives lost or major injuries due to fire, despite a few floors being destroyed: Adar Poonawalla, CEO-Owner, Serum Institute of India on incident of fire at SII's Manjri plant

tweet picture

#WATCH Maharashtra: Employees and CEO-owner of Serum Institute of India (SII) Adar Poonawalla clap at their office in Pune, as the first consignment of #Covishield  was dispatched across India today.

We've given a special price of Rs 200 for the first 100 mn doses only to GoI on their request, that we want to support common man, vulnerable, poor, healthcare workers. After that we'll be selling it at Rs 1000 in pvt markets: Adar Poonawalla, CEO-Owner, Serum Institute of India

tweet picture

A lot of countries have been writing to India & PMO for vaccines to be supplied from Serum Institute to their countries. We're trying to keep everyone happy. We've to take care of our population & nation as well: Adar Poonawalla, CEO-Owner, Serum Institute of India #Covishield 

tweet picture

We have 40-50 million doses of Covishield stockpiled. Once we get regulatory approvals in a few days, it'll be down to the Govt to decide how much they can take and how fast. We will be producing around 300 million doses by July 2021: Adar Poonawalla, Serum Institute of India

tweet picture

Vaccine will be distributed initially in India, then we will look at the COVAX countries which are mainly in Africa. The UK & European markets are being taken care of by AstraZeneca & Oxford. Our priority is India & COVAX countries: Adar Poonawalla, CEO, Serum Institute of India

tweet picture

We are in the process of applying for emergency use authorization of Covishield in the next two weeks: Serum Institute of India CEO Adar Poonawalla

tweet picture

Loading
Loading